UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032339
Receipt number R000036874
Scientific Title Brexpiprazole for the treatment of acute schizophrenia in the Japanese population
Date of disclosure of the study information 2018/04/21
Last modified on 2019/10/24 10:01:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Brexpiprazole for the treatment of acute schizophrenia in the Japanese population

Acronym

Brexpiprazole for acute schizophrenia

Scientific Title

Brexpiprazole for the treatment of acute schizophrenia in the Japanese population

Scientific Title:Acronym

Brexpiprazole for acute schizophrenia

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination whether brexpiprazole has a benefit for the treatment of acute schizophrenia

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

All causes discontinuation

Key secondary outcomes

Discontinuation due to adverse events, discontinuation due to inefficacy, the improvement of psychopathology, individual adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Brexpiprazole 2mg/day (6 weeks, open label study)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. The patient understands and agrees to all the risks and all the benefits of the proposed study
2. inpatient and outpatient
3. male and femele
4. PANSS-EC total score of. >=14 with one or more individual items scoring>=4 and CGI-S>=4
5. not receiving antipsychotic for>=2 days before the study or receiving antipsychotic (Chlorpromazine equivalent doses<=200mg/day) for>=3 days before the study

Key exclusion criteria

1. the patient with coma
2. the patient receiving anesthetic agent or barbiturate
3. the patient receiving epinephrine
4. the patient receiving psychostimulant
5. the patient having allergy brexpiprazole
6, the patient with DM
7. the patient with pregnancy
8. the patient with breast-feeding
9. the patient receiving clozapine
10. the patient suitable for clozapine
11. the patient who the clinician do not suggest to entry the study
12. the patient with mental retardation
13. the patient with dementia
14. the patient with personality disorder
15. the patient with organic brain disease and/or severe physical disease
16. the patient receiving paroxetine
17. the patient receiving carbamazepine
18. the patient receiving electroconvulsive therapy within 6 months before the study
19. the patient receiving long-acting injectable antipsychotics within 6 months before the study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nakao Iwata

Organization

Fujita Health University School of Medicine

Division name

Psychiatry

Zip code


Address

1-98 Kusukake-cho Dengakugakubo, Toyoake, Aichi 470-1192

TEL

0562-93-9250

Email

nakao@fujita-hu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taro Kishi

Organization

Fujita Health University School of Medicine

Division name

Psychiatry

Zip code


Address

1-98 Kusukake-cho Dengakugakubo, Toyoake, Aichi 470-1192

TEL

0562-93-9250

Homepage URL


Email

tarok@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田保健衛生大学(愛知県)
桶狭間病院 藤田こころケアセンター(愛知県)
藤田メンタルケアサテライト(愛知県)
藤田メンタルケアサテライト徳重北(愛知県)
仁大病院(愛知県)
聖十字病院(岐阜県)
刈谷病院(愛知県)
もりやま総合心療病院(愛知県)


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 04 Month 21 Day

Date of IRB

2018 Year 10 Month 19 Day

Anticipated trial start date

2018 Year 04 Month 21 Day

Last follow-up date

2019 Year 10 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 21 Day

Last modified on

2019 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036874


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name